EcoR1 Capital’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,250,000
| Closed | -$5.71M | – | 48 |
|
|
2025
Q1 | $5.71M | Hold |
1,250,000
| – | – | 0.34% | 29 |
|
|
2024
Q4 | $7.05M | Hold |
1,250,000
| – | – | 0.27% | 41 |
|
|
2024
Q3 | $6.05M | Hold |
1,250,000
| – | – | 0.21% | 45 |
|
|
2024
Q2 | $6.1M | Hold |
1,250,000
| – | – | 0.19% | 45 |
|
|
2024
Q1 | $16.6M | Hold |
1,250,000
| – | – | 0.42% | 39 |
|
|
2023
Q4 | $17.4M | Buy |
+1,250,000
| New | +$17.4M | 0.45% | 33 |
|
|
2022
Q3 | – | Sell |
-98,593
| Closed | -$1.51M | – | 85 |
|
|
2022
Q2 | $1.51M | Hold |
98,593
| – | – | 0.05% | 60 |
|
|
2022
Q1 | $2.25M | Sell |
98,593
-1,407
| -1% | -$32.1K | 0.07% | 62 |
|
|
2021
Q4 | $3.69M | Hold |
100,000
| – | – | 0.12% | 52 |
|
|
2021
Q3 | $4.7M | Hold |
100,000
| – | – | 0.16% | 42 |
|
|
2021
Q2 | $6.03M | Buy |
+100,000
| New | +$6.03M | 0.23% | 40 |
|